Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits. The company operates in the pharmacy services business; and markets and offers pharmacy services, including pharmacy benefit management, as well as home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services. In addition, it provides healthcare-related services and capabilities, including utilization management, behavioral health, integrated care delivery, palliative care, payment integrity services, subrogation services, and health and wellness programs, as well as services related to data management, information technology, and business operations. Further, the company is involved in the National Government Services business. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brand names. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is headquartered in Indianapolis, Indiana.

Vanguard Total Stock Mkt Idx Inv

Vanguard Institutional 500 Index Trust

The Health Care Select Sector SPDR® ETF

Capital Group Wash Mutual Invtrs Comp

American Funds Washington Mutual A

Vanguard Windsor™ II Inv

Vanguard Institutional Index I

Vanguard Dividend Appreciation ETF

T. Rowe Price Value

T. Rowe Price U.S. Value Equity Tr-Z

T. Rowe Price US Value Equity Composite

State St S&P 500® Indx SL Cl III

SPDR® S&P 500® ETF Trust

Fidelity 500 Index

iShares Core S&P 500 ETF

Vanguard Health Care Inv

Vanguard Value Index Inv

First Eagle Global A

MFS Value A

MFS Large Cap Value Equity

Vanguard Group Inc

BlackRock Inc

Morgan Stanley - Brokerage Accounts

NORGES BANK

Baillie Gifford & Co Limited.

Nuveen Asset Management, LLC

JPMorgan Chase & Co

AllianceBernstein L.P.

Artisan Partners Limited Partnership

Massachusetts Financial Services Company

Amvescap Plc.

Legal & General Group PLC

State Street Corp

T. Rowe Price Associates, Inc.

Geode Capital Management, LLC

FMR Inc

Sanders Capital, LLC

Wellington Management Company LLP

Capital Research & Mgmt Co - Division 3

Ameriprise Financial Inc

Elevance Health Inc

Ms. Gail Koziara Boudreaux

President, CEO & Director

Mr. Mark Bradley Kaye

Executive VP & CFO

Mr. Blair Williams Todt

Executive VP and Chief Legal & Administrative Officer

Mr. Peter David Haytaian Esq.

Executive VP and President of Carelon & CarelonRx

Ms. Felicia Farr Norwood

Executive VP & President of Government Health Benefits

Mr. Scott Wayne Anglin

SVP, Treasurer & Chief Investment Officer

Mr. Ronald William Penczek

Senior VP, Controller & Chief Accounting Officer

Mr. Stephen Vartan Tanal C.F.A.

Vice President of Investor Relations

Ms. Julie  Goon

Senior Vice President of Public Affairs

Mr. Kyle  Weber

Chief Strategy Officer & Interim Chief Marketing Officer

ELV's next earnings is on January 22, 2025 (Before Market Open)

ELV's latest dividend is 1.63 USD on September 10, 2024

Elevance Health Inc (ELV) Stock Analysis, Discussion Forum and Financial Metrics - NYSE Exchange

Elevance Health Inc (ELV) Earnings Report Date and History | NYSE

ELV's next earnings is on January 22, 2025 (Before Market Open)

When is the earnings report for ELV?

ELV Earnings History

ELV's latest dividend is 1.63 USD on September 10, 2024

ELV Stock Discussion Forum and Message Board

News for NYSE: ELV